Please sign in to follow a disease.

Fanconi anemia complementation group A

Clinical trials for Fanconi anemia complementation group A explained in plain language.

Never miss a new study

Get alerted when new Fanconi anemia complementation group A trials appear

Sign up with your email to follow new studies for Fanconi anemia complementation group A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 2 Terminated 1

Gene therapy aims to fix bone marrow failure in fanconi anemia

Disease control Stopped early

This trial tests a gene therapy for Fanconi anemia, a rare genetic disorder that causes bone marrow failure and increases cancer risk. Participants receive their own stem cells that have been genetically corrected with a lentiviral vector to fix the faulty FANCA gene. The study e…

Matched conditions: FANCONI ANEMIA COMPLEMENTATION GROUP A

Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

Fanconi anemia complementation group A

Get alerted when new Fanconi anemia complementation group A trials appear

Gene therapy aims to fix bone marrow failure in fanconi anemia